US authorities are looking into new groups that were formed to negotiate drug discounts but may actually be further obscuring how much the medicines cost.
Officials are working to pierce multiplying, opaque layers between the companies that make medicines and the people who take them.
Most people have never heard of these GPOs. ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.